Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy
Thomas G Cotter,1 Donald M Jensen21Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL, USA; 2Section of Hepatology, RUSH University Medical Center, Chicago, IL, USAAbstract: Direct-acting antiviral (DAA) therapy has changed the landscape of hepatitis C virus (HCV) management...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2019-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |